Global Meningococcal Vaccine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Meningococcal Vaccine market size will reach 323.62 Million USD in 2025 and is projected to reach 448.73 Million USD by 2032, with a CAGR of 4.78% (2025-2032). Notably, the China Meningococcal Vaccine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
The meningococcal vaccine is a type of immunization that helps protect against meningococcal disease, which is caused by the bacterium Neisseria meningitidis. Meningococcal disease can lead to severe infections like meningitis (inflammation of the membranes surrounding the brain and spinal cord) and septicemia (bloodstream infection). The vaccine stimulates the body’s immune system to produce a response against the specific strains of meningococcal bacteria included in the vaccine. There are different types of meningococcal vaccines available, including those targeting serogroups A, B, C, W, and Y. Some vaccines are conjugate vaccines, which offer longer-lasting protection and are often recommended for infants, adolescents, and young adults. Other vaccines may target specific high-risk populations or outbreaks. The meningococcal vaccine is typically administered through injection, and receiving the vaccine helps reduce the risk of meningococcal disease and its potentially severe complications. It is often recommended for individuals at increased risk, such as adolescents, college students living in dormitories, military recruits, and travelers to areas with high meningococcal disease rates.
The major global manufacturers of Meningococcal Vaccine include Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Zhifei, Walvax, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Meningococcal Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Meningococcal Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Meningococcal Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Meningococcal Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Meningococcal Vaccine Include:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Zhifei
Walvax
Meningococcal Vaccine Product Segment Include:
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Meningococcal Vaccine Product Application Include:
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Meningococcal Vaccine Industry PESTEL Analysis
Chapter 3: Global Meningococcal Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Meningococcal Vaccine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Meningococcal Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Meningococcal Vaccine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Meningococcal Vaccine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Meningococcal Vaccine market size will reach 323.62 Million USD in 2025 and is projected to reach 448.73 Million USD by 2032, with a CAGR of 4.78% (2025-2032). Notably, the China Meningococcal Vaccine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
The meningococcal vaccine is a type of immunization that helps protect against meningococcal disease, which is caused by the bacterium Neisseria meningitidis. Meningococcal disease can lead to severe infections like meningitis (inflammation of the membranes surrounding the brain and spinal cord) and septicemia (bloodstream infection). The vaccine stimulates the body’s immune system to produce a response against the specific strains of meningococcal bacteria included in the vaccine. There are different types of meningococcal vaccines available, including those targeting serogroups A, B, C, W, and Y. Some vaccines are conjugate vaccines, which offer longer-lasting protection and are often recommended for infants, adolescents, and young adults. Other vaccines may target specific high-risk populations or outbreaks. The meningococcal vaccine is typically administered through injection, and receiving the vaccine helps reduce the risk of meningococcal disease and its potentially severe complications. It is often recommended for individuals at increased risk, such as adolescents, college students living in dormitories, military recruits, and travelers to areas with high meningococcal disease rates.
The major global manufacturers of Meningococcal Vaccine include Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Zhifei, Walvax, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Meningococcal Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Meningococcal Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Meningococcal Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Meningococcal Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Meningococcal Vaccine Include:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Zhifei
Walvax
Meningococcal Vaccine Product Segment Include:
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Meningococcal Vaccine Product Application Include:
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Meningococcal Vaccine Industry PESTEL Analysis
Chapter 3: Global Meningococcal Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Meningococcal Vaccine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Meningococcal Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Meningococcal Vaccine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Meningococcal Vaccine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Meningococcal Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Meningococcal Vaccine Product by Type
- 1.2.1 Meningtits A
- 1.2.2 Polysaccharide Meningtitis AC
- 1.2.3 Meningitis ACYW
- 1.3 Meningococcal Vaccine Product by Application
- 1.3.1 6 Months-15Year
- 1.3.2 over 3 Year
- 1.3.3 over 2 Year
- 1.3.4 over 3 Months
- 1.4 Global Meningococcal Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Meningococcal Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Meningococcal Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Meningococcal Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Meningococcal Vaccine Market Development Status and Trends
- 1.5.1 Meningococcal Vaccine Industry Development Status Analysis
- 1.5.2 Meningococcal Vaccine Industry Development Trends Analysis
- 2 Meningococcal Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Meningococcal Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Meningococcal Vaccine Market Analysis by Country
- 4.1 Global Meningococcal Vaccine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Meningococcal Vaccine Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Meningococcal Vaccine Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Meningococcal Vaccine Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Meningococcal Vaccine Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Meningococcal Vaccine Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Meningococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Meningococcal Vaccine Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Meningococcal Vaccine Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Meningococcal Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Meningococcal Vaccine Average Sales Price by Manufacturers (2021-2025)
- 5.2 Meningococcal Vaccine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Meningococcal Vaccine Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Meningococcal Vaccine Market Analysis by Type
- 6.1 Global Meningococcal Vaccine Market Revenue Analysis by Type
- 6.1.1 Global Meningococcal Vaccine Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Meningococcal Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Meningococcal Vaccine Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Meningococcal Vaccine Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Novartis
- 7.1.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Novartis Meningococcal Vaccine Product Portfolio
- 7.1.3 Novartis Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 GSK
- 7.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 GSK Meningococcal Vaccine Product Portfolio
- 7.2.3 GSK Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Merck
- 7.3.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Merck Meningococcal Vaccine Product Portfolio
- 7.3.3 Merck Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 CSL
- 7.4.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 CSL Meningococcal Vaccine Product Portfolio
- 7.4.3 CSL Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Baxter
- 7.5.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Baxter Meningococcal Vaccine Product Portfolio
- 7.5.3 Baxter Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 JN International Medical Corporation
- 7.6.1 JN International Medical Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 JN International Medical Corporation Meningococcal Vaccine Product Portfolio
- 7.6.3 JN International Medical Corporation Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Serum Institute of India
- 7.7.1 Serum Institute of India Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Serum Institute of India Meningococcal Vaccine Product Portfolio
- 7.7.3 Serum Institute of India Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Bio-Med
- 7.8.1 Bio-Med Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Bio-Med Meningococcal Vaccine Product Portfolio
- 7.8.3 Bio-Med Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 China National Biotec Group
- 7.9.1 China National Biotec Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 China National Biotec Group Meningococcal Vaccine Product Portfolio
- 7.9.3 China National Biotec Group Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Hualan Bio
- 7.10.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Hualan Bio Meningococcal Vaccine Product Portfolio
- 7.10.3 Hualan Bio Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Zhifei
- 7.11.1 Zhifei Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Zhifei Meningococcal Vaccine Product Portfolio
- 7.11.3 Zhifei Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 Walvax
- 7.12.1 Walvax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Walvax Meningococcal Vaccine Product Portfolio
- 7.12.3 Walvax Meningococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Meningococcal Vaccine Industry Chain Analysis
- 8.2 Meningococcal Vaccine Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Meningococcal Vaccine Product Downstream Application Analysis
- 8.3.1 Global Meningococcal Vaccine Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Meningococcal Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Meningococcal Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Meningococcal Vaccine Typical Downstream Customers
- 8.5 Meningococcal Vaccine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
